NOX
Noxopharm Limited
๐ฆ๐บ ASX
๐งฌ BIOTECHNOLOGY
๐ Overview
๐ Performance
๐ต Cost
๐ค Advanced
๐จโ๐ฉโ๐งโ๐ฆ Community
๐
-13.30%
Annual Growth
5 years average annual growth
๐ต
$ 500
Minimum Order
Due to regulatory requirements
๐
3
Pearlers Invested
Since January 2020
๐ Overview
Key information
๐ Fund Overview
Noxopharm Ltd. engages in the research and development of drugs. The company is headquartered in Castle Hill, New South Wales and currently employs 1,000 full-time employees. The company went IPO on 2016-08-09. The company is engaged in discovering and developing novel treatments for cancer and inflammation, including a pioneering technology to enhance messenger ribonucleic acid (mRNA) vaccines. The company utilizes specialist in-house capabilities and partnerships with researchers to build a pipeline of new proprietary drugs based on two technology platforms: Chroma (oncology) and Sofra (inflammation, autoimmunity, and mRNA vaccine enhancement). Chroma is a technology platform focused on the development of multiple drug candidates, primarily for cancer treatment. The Sofra technology platform has a pipeline of proprietary drugs based on oligonucleotides, the building blocks of deoxyribonucleic acid (DNA), with a focus on mRNA vaccines and the treatment of autoimmune and inflammatory diseases. SOF-VAC has applications in the treatment of excessive inflammatory responses associated with specialized inflammatory receptors in the body known as Toll-like receptor 7.
๐ Performance
Price History
-40.55%
1M
1Y
All Time
Graph
Table
Unsure how much or often to invest?
๐๏ธ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out โ๐ต Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out โโฑ๏ธ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out โ๐ต Costs
๐ผ
N/A
Management Fee
Included in unit price, not charged by Pearler
๐ธ
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
๐ธ Net fee calculator๐ค Advanced information
Technical Info
๐ฐ Price*
$0.10
*Price may be up to 24 hours old
๐ฉโ๐ฉโ๐ฆ Community Insights
How our community is investing
๐ Pearlers invested in NOX
3
๐ Total Capital Earnings
$3K
๐ Average investment frequency
33 weeks
๐ต Average investment amount
$1,696
โฐ Last time a customer invested in NOX
263 days
NOX investor breakdown
๐ต Income of investors
More than 200k
150k - 200k
100k - 150k
33%
50k - 100k
33%
Less than 50k
33%
๐ถ Age of investors
18 - 25
26 - 34
100%
35 - 90
๐ Legal gender of investors
Female
Male
100%
Pearlers who invest in NOX also invest in...
VAS.AX was created on 2009-05-04 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard Australian Shares Index ETF seeks to track the return of the S&P/ASX 300 Index before taking into account fees, expenses and tax.
๐ Performance (5Yr p.a)
4.35%
๐ Share price
$104.33 AUD
โณ๏ธ DIVERSIFIED
๐งฑ MATERIALS
๐ธ FINANCIALS
VDHG.AX was created on 2017-11-20 by Vanguard. The fund's investment portfolio concentrates primarily on target outcome asset allocation. Vanguard Diversified High Growth Index ETF seeks to track the weighted average return of the various indices of the underlying funds in which it invests, in proportion to the Strategic Asset Allocation, before taking into account fees, expenses and tax.
๐ Performance (5Yr p.a)
4.00%
๐ Share price
$68.57 AUD
โณ๏ธ DIVERSIFIED
๐ GLOBAL
VESG.AX was created on 2018-09-11 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard Ethically Conscious International Shares Index ETF seeks to track the return of the FTSE Developed ex Australia Choice Index (with net dividends reinvested) in Australian dollars before taking into account fees, expenses and tax
๐ Performance (5Yr p.a)
14.40%
๐ Share price
$97.21 AUD
๐ค TECHNOLOGY
๐ HIGH PRICE GROWTH
๐ GLOBAL
โณ๏ธ DIVERSIFIED
MVW.AX was created on 2014-03-04 by VanEck. The fund's investment portfolio concentrates primarily on large cap equity. MVW.AX invests in a diversified portfolio of ASX-listed securities with the aim of providing investment returns before fees and other costs that track the performance of the MVIS Australia Equal Weight Index
๐ Performance (5Yr p.a)
4.42%
๐ Share price
$38.71 AUD
๐งฑ MATERIALS
ACDC.AX was created on 2018-08-30 by Global X. The fund's investment portfolio concentrates primarily on theme equity. The Fund aims to provide investors with a return that (before fees and expenses) tracks the performance of the Solactive Battery ValueChain Index (the Index).
๐ Performance (5Yr p.a)
12.66%
๐ Share price
$82.30 AUD
๐ค TECHNOLOGY
๐ญ INDUSTRIALS
๐ HIGH PRICE GROWTH
๐ GLOBAL
๐๏ธ CONSUMER
Want more shares? Try these...
NewPeak Metals Ltd. engages in coal and lithium exploration in Argentina, oil and gas in Australia, and gold exploration in U.S. Its projects include cachi gold, san Jorge lithium brine and las openas gold. The company is headquartered in Brisbane, Queensland. The company went IPO on 2011-04-11. The firm has gold exploration assets in three of the mining jurisdictions globally: Finland, Argentina and New Zealand. The company has a suite of gold projects in a region in Finland which hosts three gold mines, Orivesi, Jokisivu and Kaapelinkulma. The Las Openas Gold Project is located in the province of San Juan, with a lease area of approximately 1,462 hectares. The Cachi Gold Project is a Caldera hosted epithermal gold vein system spanning approximately 10 kilometers across and five kilometers in width. The company owns a 75% stake in the Cap Burn Gold Project, in Otago, New Zealand, through an earn-in joint venture with Mineral Rangahau Joint Venture. The company has 100% ownership in several other gold properties, between OceanaGoldโs Macraes Mine in the east, and the Santana-Matakanui Bendigo-Ophir project in the west. The company also has a group of mineral and tungsten exploration assets in Sweden.
๐ Performance (5Yr p.a)
48.57%
๐ Share price
$0.01 AUD
โ๏ธ MINING
๐ HIGH PRICE GROWTH